Cheng Wang

Title: Cheng Wang: Innovator in Gene-Editing Technology

Introduction

Cheng Wang is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of gene-editing technology, particularly through his innovative patent that enhances the delivery of gene-editing systems.

Latest Patents

Cheng Wang holds a patent titled "Delivery of a gene-editing system with a single retroviral particle and methods of generation and use." This invention provides a recombinant RNA molecule that includes a sequence of a gene-editing molecule mRNA and at least one sequence of a coding or non-coding enrichment RNA. The enrichment RNA is designed to enhance the inclusion of the gene-editing molecule mRNA into a retroviral particle. The patent outlines a method for producing these retroviral particles by culturing a packaging cell under conditions conducive to the production of multiple retroviral particles. He has 1 patent to his name.

Career Highlights

Cheng Wang is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in gene-editing technologies. His work at Regeneron has positioned him as a key player in advancing therapeutic innovations.

Collaborations

Cheng has collaborated with notable colleagues, including Christos Kyratsous and Andrew J Murphy, contributing to a dynamic research environment focused on groundbreaking advancements in biotechnology.

Conclusion

Cheng Wang's contributions to gene-editing technology exemplify the innovative spirit of modern science. His work continues to pave the way for advancements in therapeutic applications, showcasing the importance of collaboration and creativity in the field.